More articles from Novel Probe Development III

You have access
Evaluation of 64Cu-DOTA-KCCYSL and 64Cu-CB-TE2A-KCCYSL peptides as PET imaging agents for ErbB-2 expressing breast carcinomas
Senthil Kumar, Fabio Gallazzi, Riccardo Ferdani, Carolyn Anderson, Thomas Quinn and Susan Deutscher

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 372;
You have access
F-18-Labeled cyclen-Zn(II) complexes for in vivo imaging of apoptosis
Doerte Oltmanns, Martin Schaefer and Michael Eisenhut

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 371;
You have access
Analysis of metabolites of Cu-64 labeled DOTA PEGylated star-like copolymeric nanoparticles
Tetsuya Mori, Aviv Hagooly, Eric Pressly, Ken-ichi Fukukawa, Craig Hawker and Michael Welch

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 374;
You have access
Evaluating bifuctional chelates for antibody imaging with Cu-64
Cara Ferreira, Donald Yapp, Sarah Crisp, Brent Sutherland, Martin Gleave, Corrine Bensimon, Paul Jurek and Garry Kiefer

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 373;
You have access
New carbon-11 labeled 4-aryl-4H-chromenes as PET agents for imaging of apoptosis
Mingzhang Gao, Min Wang, Kathy Miller, Gary Hutchins and Qi-Huang Zheng

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 370;
You have access
Identification of the optimal Cu-64 bifunctional chelator for radioimmunodetection of neuroblastoma
Jason Dearling, Stephan Voss, Patricia Dunning, Erin Snay, Frederick Fahey, Claude Meares, Ted Treves, Suzanne Smith and Alan Packard

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 375;
You have access
68Ga-glucosamine analogs for PET imaging of cancer
Izabela Tworowska, Hitomi Saso, Jennifer Sims-Mourtada, Firas Mourtada, Ebrahim Delpassand and Ali Azhdarinia

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 376;

Main menu

User menu

Search

More articles from Novel Probe Development III